Similar to BRCA1, the potential application of NBR2 as a cancer biomarker was initially revealed in breast cancer, as the expression of NBR2 decreased in primary cancer cells derived from human breast cancer tissues (61). This evidence concerns the gene BRCA1 and breast cancer.